AIDOC Funding: $500M Raised, Series E (2026)

AIDOC funding overview

AIDOC is a Healthtech company based in Tel Aviv, Israel. AIDOC has raised $500M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in April 2026. The round record for AIDOC runs through 2026; nothing later has been disclosed. Investors on record include Goldman Sachs Alternatives, General Catalyst, SoftBank Vision Fund 2, NVentures, TCV, Alpha Intelligence Capital and 2 others. 8 distinct backers are named across the disclosed rounds.

AIDOC at a glance

Total raised: $500M
Latest round: Series E
Latest round date: April 2026
Industry: Healthtech
Headquarters: Tel Aviv, Israel
Notable investors: Goldman Sachs Alternatives, General Catalyst, SoftBank Vision Fund 2, NVentures, TCV, Alpha Intelligence Capital, CDIB Capital, Square Peg

Frequently asked about AIDOC funding

How much has AIDOC raised?: AIDOC has raised $500M in total disclosed funding across the rounds on record.
Who has invested in AIDOC?: Goldman Sachs Alternatives, General Catalyst, SoftBank Vision Fund 2, NVentures, TCV, Alpha Intelligence Capital are named among the investors backing AIDOC.
What was the latest AIDOC funding round?: The most recent disclosed round is a Series E, announced in April 2026.
Where is AIDOC based?: AIDOC is based in Tel Aviv, Israel.
What sector does AIDOC operate in?: AIDOC is tracked under Healthtech from Tel Aviv, Israel, with $500M in disclosed funding.
When did AIDOC last raise?: The last disclosed AIDOC round closed in April 2026 at Series E.

AIDOC totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Healthtech companies in Tel Aviv below to benchmark round size and investor mix.

AIDOC Funding: $500M Raised, Series E (2026)

AIDOC funding overview

AIDOC at a glance

Frequently asked about AIDOC funding

AIDOC founders (1)

Companies related to AIDOC (40)

Browse related funding lists (9)